// App-Quantinova.ai

3920 : Unique Long Non-Coding RNA Expression Signature in ETV6/RUNX1-Driven B-Cell Precursor Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Barbara De Moerloose

Principal Investigators

  • Wouter Van Loocke

  • Annelynn Wallaert

  • Frank Speleman

  • Yves Benoit

  • Tim Lammens

  • Pieter Van Vlierberghe

  • Alina Ferster

  • Marleen Bakkus

  • Genevieve PLAT

  • Eric Delabesse

  • Anne Uyttebroeck

  • Filip Van Nieuwerburgh

  • Dieter Deforce

  • Nadine Van Roy

Medical Centers

  • Department of Hemato-Oncology, HUDERF, Brussels, Belgium

  • Cancer Research Institute Ghent (CRIG), Ghent, Belgium

  • Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium

  • Laboratoire dImmunologie, CHU de Toulouse, Toulouse, France

  • Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium

  • Department of Hematology, University Hospital Leuven, Leuven, Belgium

  • Department of Urology, Hopital Rangueil, Toulouse, France

  • Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium

  • Centre for Medical Genetics, Ghent University Hospital, Ghent, Belgium

  • Department of Hematology, University Hospital Brussels, Vrije Universiteit Brussel (VUB), Brussels, Belgium

Locations

  • France

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • ETV6-RUNX1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved